OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NARM56

Narmada Gelatines Ltd

Specialty ChemicalsVerified

Narmada Gelatines Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.11, significantly below the median for the Specialty Chemicals industry, and a current ratio of 2.55, indicating strong short-term liquidity. However, the company's free cash flow is negative at -13.19 million INR, driven by capital expenditures of -147.00 million INR, suggesting ongoing investment in operations. Profitability metrics show a return on equity of 14.41% and a return on assets of 10.8%, both exceeding the industry median for Specialty Chemicals. The company's operating margin of 11.84% (calculated from operating income of 223.59 million INR on revenue of 1,889.21 million INR) is robust, though the gross margin of 28.20% (532.62 million INR on revenue of 1,889.21 million INR) is in line with industry norms. The company's revenue is concentrated in a single business segment, gelatin and related products, with no disclosed geographic diversification. This concentration increases exposure to sector-specific demand fluctuations and supply chain risks. Outlook for the current fiscal year shows a projected revenue growth of 5.0% year-over-year, with a net income growth of 3.5%. For the next fiscal year, revenue is expected to grow by 4.0%, with net income growth of 2.0%, reflecting stable but moderate expansion. Risk factors include a medium liquidity risk due to negative net cash after subtracting total debt, and a low dilution potential as shares outstanding remain unchanged between basic and diluted measures. No recent dilutive events are reported, and no adjustments are applied to valuation metrics. Recent filings and transcripts do not disclose material events affecting operations or strategy. The company's 10-K filing highlights ongoing investments in production capacity and adherence to regulatory standards for gelatin processing.

30-day price · NARM+45.00 (+12.8%)
Low$335.75High$440.00Close$396.80As of15 May, 00:00 UTC
Profile
CompanyNarmada Gelatines Ltd
TickerNARM.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Narmada Gelatines Ltd is engaged in the manufacture and sale of gelatin and related products, including ossein and di-calcium phosphate (DCP) for industrial applications, with operations in Jabalpur, Madhya Pradesh.

Classification. Narmada Gelatines Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Narmada Gelatines Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.11, significantly below the median for the Specialty Chemicals industry, and a current ratio of 2.55, indicating strong short-term liquidity. However, the company's free cash flow is negative at -13.19 million INR, driven by capital expenditures of -147.00 million INR, suggesting ongoing investment in operations. Profitability metrics show a return on equity of 14.41% and a return on assets of 10.8%, both exceeding the industry median for Specialty Chemicals. The company's operating margin of 11.84% (calculated from operating income of 223.59 million INR on revenue of 1,889.21 million INR) is robust, though the gross margin of 28.20% (532.62 million INR on revenue of 1,889.21 million INR) is in line with industry norms. The company's revenue is concentrated in a single business segment, gelatin and related products, with no disclosed geographic diversification. This concentration increases exposure to sector-specific demand fluctuations and supply chain risks. Outlook for the current fiscal year shows a projected revenue growth of 5.0% year-over-year, with a net income growth of 3.5%. For the next fiscal year, revenue is expected to grow by 4.0%, with net income growth of 2.0%, reflecting stable but moderate expansion. Risk factors include a medium liquidity risk due to negative net cash after subtracting total debt, and a low dilution potential as shares outstanding remain unchanged between basic and diluted measures. No recent dilutive events are reported, and no adjustments are applied to valuation metrics. Recent filings and transcripts do not disclose material events affecting operations or strategy. The company's 10-K filing highlights ongoing investments in production capacity and adherence to regulatory standards for gelatin processing.
Key takeaways
  • Narmada Gelatines Ltd maintains a strong liquidity position with a current ratio of 2.55 and a low debt-to-equity ratio of 0.11.
  • The company's profitability metrics, including ROE of 14.41% and ROA of 10.8%, outperform the industry median.
  • Revenue is concentrated in a single product line, increasing exposure to sector-specific risks.
  • Outlook for the next two fiscal years shows moderate growth, with revenue and net income expected to increase by 4.0% and 2.0%, respectively.
  • The company faces medium liquidity risk due to negative net cash after debt, but dilution risk remains low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.89B
Gross profit$532.6M
Operating income$223.6M
Net income$172.1M
R&D
SG&A
D&A
SBC
Operating cash flow$170.4M
CapEx-$147.0M
Free cash flow-$13.2M
Total assets$1.59B
Total liabilities$398.9M
Total equity$1.19B
Cash & equivalents
Long-term debt$127.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.19B
Net cash-$127.2M
Current ratio2.5
Debt/Equity0.1
ROA10.8%
ROE14.4%
Cash conversion99.0%
CapEx/Revenue-7.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricNARMActivity
Op margin11.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin9.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin28.2%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-7.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity11.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 13:14 UTC#56e70a77
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 19:31 UTCJob: cf9c19df